Key statistics
On Friday, Contineum Therapeutics Inc (CTNM:NSQ) closed at 14.09, 14.27% above the 52 week low of 12.33 set on Nov 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.43 |
---|---|
High | 14.82 |
Low | 13.92 |
Bid | 14.09 |
Offer | 15.76 |
Previous close | 14.34 |
Average volume | 70.19k |
---|---|
Shares outstanding | 25.78m |
Free float | 16.91m |
P/E (TTM) | -- |
Market cap | 369.65m USD |
EPS (TTM) | -1.39 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
- Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain
- Contineum Therapeutics to Attend Upcoming Investor Conferences
- Contineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
- Contineum Therapeutics to Present at Multiple Upcoming Investor Conferences